| Net Cash Provided by (Used in) Operating Activities |
$48,799,000 |
USD |
-15% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$295,876,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$175,325,000 |
USD |
-171% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
166,666,667 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
83,402,145 |
shares |
3.1% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$169,350,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$284,465,000 |
USD |
239% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$121,753,000 |
USD |
1.2% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$102,182,000 |
USD |
-7.7% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$104,568,000 |
USD |
-5.5% |
Q4 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$217,344,000 |
USD |
45% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$97,255,000 |
USD |
-9.2% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$2,386,000 |
USD |
|
Q4 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$11,000,000 |
USD |
38% |
Q4 2025 |
FY 2025 |
| Interest Expense |
$511,395,000 |
USD |
32% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |